[144] AvePoint, Inc. SEC Filing

Rhea-AI Filing Summary

AvePoint, Inc. insider sale notice: The filing reports a proposed sale of 35,000 shares of common stock by a person associated with AVPT through Rockefeller Financial with an aggregate market value of $540,484.90, with an approximate sale date of 08/25/2025. The shares were acquired as a restricted stock grant on 07/07/2022 and were granted as compensation. The issuer has 211,926,808 shares outstanding. The filer previously sold three blocks of 35,000 shares on 05/23/2025, 06/23/2025 and 07/23/2025 with gross proceeds of $635,482.33, $638,057.00 and $654,941.73 respectively. The signer represents no undisclosed material adverse information and notes Rule 144 sale reporting requirements.

Positive

• Full compliance with Rule 144 disclosure requirements, including acquisition date, nature of acquisition, broker and sale dates
• Transparent record of recent sales with specific gross proceeds for May, June and July 2025
• Filer represents no undisclosed material adverse information, consistent with required certifications

Negative

• None.

Insights

Securities Analyst

TL;DR: Routine Rule 144 insider sale of 35,000 shares; proceeds and timing disclosed, not material to market capitalization.

The notice documents a planned sale of 35,000 shares via Rockefeller Financial valued at $540,484.90, representing a small fraction of the issuer's 211,926,808 outstanding shares. The position was acquired as a restricted stock grant on 07/07/2022 and was granted as compensation, consistent with typical post-vesting disposals under Rule 144. Three prior identical-size sales in the past three months are disclosed with gross proceeds listed, which provides transparent execution history. There is no disclosure of material nonpublic information and no facts here that indicate a material corporate event.

Corporate Governance Expert

TL;DR: Disclosure aligns with Rule 144 procedures; repeated monthly sales are documented but not flagged as material.

The filing fulfills required disclosures for an insider sale under Rule 144, including acquisition date, nature of acquisition (restricted stock grant), transaction broker, and sale schedule. The filer affirms no knowledge of undisclosed material adverse information. The record of three prior monthly sales plus this proposed sale demonstrates an ongoing disposition pattern, which is properly reported here. No governance irregularities or compliance failures are evident from the filing text alone.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Rockefeller Financial 200 South 10th Street Suite 950 Richmond VA 23219	35000	540484.90	211926808	08/25/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/07/2022	Restricted Stock Grant	AVPT			35000	07/07/2022	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Brown Brian Michael 4101 WELBY DR MIDLOTHIAN VA 23113	Common	05/23/2025	35000	635482.33
Brown Brian Michael 4101 WELBY DR MIDLOTHIAN VA 23113	Common	06/23/2025	35000	638057.00
Brown Brian Michael 4101 WELBY DR, MIDLOTHIAN VA 23113	Common	07/23/2025	35000	654941.73

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What securities does the AVPT Form 144 report propose to sell?

The filing proposes the sale of 35,000 shares of AvePoint, Inc. common stock with an aggregate market value of $540,484.90.

Who is the seller identified in the filing?

The recent sales listed name Brown Brian Michael at an address in Midlothian, VA, as the seller for three prior sales; the proposed sale lists a person for whose account the securities are to be sold associated with AVPT.

How and when were the shares acquired?

The 35,000 shares were acquired as a restricted stock grant on 07/07/2022 and the nature of payment is listed as compensation.

What recent sales by the same person are disclosed?

The filer sold 35,000 shares on 05/23/2025 (gross proceeds $635,482.33), 06/23/2025 ($638,057.00), and 07/23/2025 ($654,941.73).

Does the filing state whether the seller knows any material nonpublic information?

Yes. By signing the notice the person represents that they do not know any material adverse information